| Product Candidates/Indications | Research | Pre-clinical | Phase 1 | Phase 2 | Phase 3 | Partnership |
|---|---|---|---|---|---|---|
| BNZ-1 (IL-2, IL-9, IL-15) |
 option to buy |
|||||
| Cutaneous T-cell Lymphoma (CTCL) |
|
|||||
| Alopecia Areata |
|
|||||
| BNZ-2 (IL-15, IL-21) subcutaneous delivery | ||||||
| Celiac Disease |
|
|||||
| Inflammatory Bowel Disease (s.c.) |
|
|||||
| BNZ-3 (IL-15, IL-21) oral delivery | ||||||
| Celiac Disease |
|
|||||
| Product Candidates/Indications | Phase | Partnership |
|---|---|---|
| BNZ-1 (IL-2, IL-15) |
option to buy |
|
| Cutaneous T-cell Lymphoma (CTCL) |
Phase 2
|
|
| Alopecia Areata |
Phase 1 Completed
|
|
| BNZ-2 (IL-15, IL-21) subcutaneous delivery | ||
| Celiac Disease |
Phase 1
|
|
| Inflammatory Bowel Disease (s.c.) |
Research
|
|
| BNZ-3 (IL-15, IL-21) oral delivery | ||
| Celiac Disease |
Research
|
|